Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT), most recent 12 months reported: revenue $308.08M, net loss $63.85M, free cash flow -$24.03M. Latest balance sheet on file: liquid cash $344.25M, total debt $334.88M, net cash $9.38M. From SEC filings. More on ADAPTIVE BIOTECHNOLOGIES CORPORATION: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): Immunocore Holdings plc · NOVAVAX INC · MeiraGTx Holdings plc · IOVANCE BIOTHERAPEUTICS, INC. · VERICEL CORPORATION · Vir Biotechnology, Inc. · Vaxart, Inc. · REGENXBIO Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.